🚀 Advance Your Autoimmune Research with Pharmidex!
August 7, 2024
Pharmidex offers comprehensive in vitro and preclinical solutions for autoimmune diseases like multiple sclerosis, psoriasis, atopic dermatitis, alopecia, and vitiligo. Our extensive expertise combines proof of concept studies with pharmacokinetic, pharmacodynamic, toxicological, and bioanalytical endpoints to fast-track your research programs.
🔬 Partner with us to accelerate your path to groundbreaking treatments.

We are pleased to share that Ian Knowles and Martin Barrett will attend Pharmacology 2025, organized by The British Pharmacological Society (BPS), at the ICC Belfast from 16–18 December 2025. They will host a Pharmidex exhibition stand, showcasing our key services and their importance in drug discovery and development. Ian and Martin will be delighted to meet attendees, exchange ideas, and explore new collaboration opportunities. Come and say hello!

Head of Respiratory at Pharmidex , Ian Knowles will be attending the Drug Delivery to the Lungs Conference (DDL) on 10–12 December 2025 at the Edinburgh International Conference Centre. DDL brings together global leaders in pulmonary and respiratory drug delivery, and Ian looks forward to meeting fellow attendees, exploring collaborations, and discussing how Pharmidex can support and accelerate drug discovery and development across industry and academia. If you’ll be there too, feel free to reach out we look forward to building new connections and advancing innovation together.





